リニカルの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/12/12 | 1,587 | 1,598 | 1,560 | 1,560 | -32 | -2% | 65,300 |
| 2017/12/11 | 1,590 | 1,604 | 1,580 | 1,592 | +8 | +0.5% | 51,000 |
| 2017/12/08 | 1,550 | 1,604 | 1,550 | 1,584 | +33 | +2.1% | 112,400 |
| 2017/12/07 | 1,551 | 1,577 | 1,547 | 1,551 | -2 | -0.1% | 93,400 |
| 2017/12/06 | 1,551 | 1,566 | 1,540 | 1,553 | ±0 | ±0% | 90,100 |
| 2017/12/05 | 1,551 | 1,560 | 1,537 | 1,553 | +3 | +0.2% | 62,700 |
| 2017/12/04 | 1,558 | 1,595 | 1,549 | 1,550 | -5 | -0.3% | 99,700 |
| 2017/12/01 | 1,549 | 1,558 | 1,532 | 1,555 | +10 | +0.6% | 90,900 |
| 2017/11/30 | 1,519 | 1,556 | 1,518 | 1,545 | +40 | +2.7% | 226,000 |
| 2017/11/29 | 1,509 | 1,513 | 1,498 | 1,505 | -6 | -0.4% | 129,200 |
| 2017/11/28 | 1,510 | 1,525 | 1,496 | 1,511 | +10 | +0.7% | 67,400 |
| 2017/11/27 | 1,523 | 1,534 | 1,498 | 1,501 | -20 | -1.3% | 95,700 |
| 2017/11/24 | 1,510 | 1,530 | 1,496 | 1,521 | +30 | +2% | 102,900 |
| 2017/11/22 | 1,501 | 1,513 | 1,473 | 1,491 | -9 | -0.6% | 100,500 |
| 2017/11/21 | 1,485 | 1,510 | 1,470 | 1,500 | +30 | +2% | 175,900 |
| 2017/11/20 | 1,420 | 1,477 | 1,415 | 1,470 | +51 | +3.6% | 158,700 |
| 2017/11/17 | 1,405 | 1,431 | 1,405 | 1,419 | +21 | +1.5% | 96,700 |
| 2017/11/16 | 1,340 | 1,416 | 1,340 | 1,398 | +50 | +3.7% | 158,600 |
| 2017/11/15 | 1,352 | 1,371 | 1,338 | 1,348 | -11 | -0.8% | 116,000 |
| 2017/11/14 | 1,375 | 1,381 | 1,342 | 1,359 | -30 | -2.2% | 123,600 |
| 2017/11/13 | 1,387 | 1,390 | 1,355 | 1,389 | +2 | +0.1% | 96,300 |
| 2017/11/10 | 1,359 | 1,389 | 1,337 | 1,387 | +30 | +2.2% | 156,900 |
| 2017/11/09 | 1,463 | 1,465 | 1,332 | 1,357 | -108 | -7.4% | 529,200 |
| 2017/11/08 | 1,479 | 1,483 | 1,452 | 1,465 | -6 | -0.4% | 55,600 |
| 2017/11/07 | 1,463 | 1,482 | 1,463 | 1,471 | +5 | +0.3% | 62,800 |
| 2017/11/06 | 1,479 | 1,495 | 1,465 | 1,466 | -13 | -0.9% | 105,800 |
| 2017/11/02 | 1,497 | 1,506 | 1,472 | 1,479 | -15 | -1% | 90,600 |
| 2017/11/01 | 1,500 | 1,520 | 1,482 | 1,494 | +7 | +0.5% | 126,600 |
| 2017/10/31 | 1,463 | 1,520 | 1,434 | 1,487 | -108 | -6.8% | 354,700 |
| 2017/10/30 | 1,570 | 1,613 | 1,570 | 1,595 | +29 | +1.9% | 122,300 |
| 2017/10/27 | 1,547 | 1,570 | 1,533 | 1,566 | +25 | +1.6% | 68,800 |
| 2017/10/26 | 1,525 | 1,547 | 1,525 | 1,541 | +19 | +1.2% | 42,700 |
| 2017/10/25 | 1,587 | 1,590 | 1,518 | 1,522 | -54 | -3.4% | 176,400 |
| 2017/10/24 | 1,563 | 1,588 | 1,537 | 1,576 | +25 | +1.6% | 164,500 |
| 2017/10/23 | 1,524 | 1,559 | 1,512 | 1,551 | +43 | +2.9% | 131,700 |
| 2017/10/20 | 1,491 | 1,536 | 1,490 | 1,508 | +8 | +0.5% | 226,400 |
| 2017/10/19 | 1,491 | 1,507 | 1,490 | 1,500 | +6 | +0.4% | 40,500 |
| 2017/10/18 | 1,494 | 1,501 | 1,486 | 1,494 | ±0 | ±0% | 33,900 |
| 2017/10/17 | 1,513 | 1,513 | 1,487 | 1,494 | -13 | -0.9% | 47,500 |
| 2017/10/16 | 1,514 | 1,514 | 1,492 | 1,507 | +9 | +0.6% | 53,900 |
| 2017/10/13 | 1,508 | 1,508 | 1,489 | 1,498 | -8 | -0.5% | 52,600 |
| 2017/10/12 | 1,497 | 1,528 | 1,494 | 1,506 | +5 | +0.3% | 78,300 |
| 2017/10/11 | 1,500 | 1,510 | 1,482 | 1,501 | +5 | +0.3% | 65,900 |
| 2017/10/10 | 1,496 | 1,518 | 1,491 | 1,496 | -8 | -0.5% | 65,700 |
| 2017/10/06 | 1,511 | 1,511 | 1,484 | 1,504 | ±0 | ±0% | 89,100 |
| 2017/10/05 | 1,566 | 1,566 | 1,498 | 1,504 | -43 | -2.8% | 177,200 |
| 2017/10/04 | 1,500 | 1,551 | 1,496 | 1,547 | +50 | +3.3% | 153,300 |
| 2017/10/03 | 1,523 | 1,523 | 1,487 | 1,497 | -16 | -1.1% | 106,300 |
| 2017/10/02 | 1,510 | 1,529 | 1,506 | 1,513 | +10 | +0.7% | 73,000 |
| 2017/09/29 | 1,499 | 1,512 | 1,496 | 1,503 | -5 | -0.3% | 56,100 |
1851～
1900
件表示中 / 4086件
類似銘柄と比較する
現在ご覧いただいている「リニカル」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| リニカル | 33,400円 | +7.3% | - | 4.79% | 50.30倍 | 1.04倍 |
|
新薬の治験支援（ＣＲＯ）専業。がん、中枢神経、免疫系から再生医療等展開。市販後調査強化 |
| 博 展 | 51,500円 | +10.9% | +4.3% | 3.88% | 7.96倍 | 2.40倍 |
|
イベントや展示会、販売促進を支援。リアルとデジタルの融合提案を拡充。配当性向３０％メド |
| Ｚｅｎｋｅｎ | 67,100円 | +6.6% | +43.6% | 1.94% | 21.45倍 | 0.67倍 |
|
Ｗｅｂマーケティングやサイト制作・運用が柱。インド軸に海外ＩＴ人材紹介。語学、不動産も |
| セルム | 35,800円 | +27.3% | +7.2% | 4.19% | 12.14倍 | 2.86倍 |
|
大企業の組織づくりや人材育成を支援。グローバル企業顧客向け多言語対応支援領域にも参入 |
| ビステム | 84,000円 | +5.3% | +18.8% | 3.57% | 8.08倍 | 0.84倍 |
|
ビルメンテ中堅。独立系。首都圏中心。大型複合施設などの民間建物管理やＰＰＰ事業を拡大中 |
市場注目の銘柄
チャート関連のコラム
